Limitations in the neuroprotective potential of gene therapy with Bcl-2

Citation
Rg. Phillips et al., Limitations in the neuroprotective potential of gene therapy with Bcl-2, BRAIN RES, 859(2), 2000, pp. 202-206
Citations number
29
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BRAIN RESEARCH
ISSN journal
00068993 → ACNP
Volume
859
Issue
2
Year of publication
2000
Pages
202 - 206
Database
ISI
SICI code
0006-8993(20000324)859:2<202:LITNPO>2.0.ZU;2-E
Abstract
Considerable attention has focused on the therapeutic transfer of genes wit h viral vectors into neurons for the purpose of protecting against neurolog ical insults. A number of papers have reported that overexpression of the a nti-apoptotic protein Bcl-2 can protect neurons both in vitro and in vivo a gainst a variety of necrotic insults. An emerging literature suggests that the availability of energy tends to modulate a neuron towards dying apoptot ically, rather than necrotically, in the aftermath of an insult. This sugge sts that an anti-apoptotic protein such as Bcl-2 should be minimally protec tive, at best, against purely energetic insults. In support of this idea, w e report that overexpression of Bcl-2 with a herpes simplex viral vector fa ils to protect hippocampal neurons, either in vitro or in vivo, against the electron transport uncoupler 3-acetylpyridine (3AP). As a positive control , the same vector significantly protected against the excitotoxin kainic ac id. This finding supports the view that neurotoxicity induced by 3AP is lik ely to have only minimal apoptotic facets. On a broader level, it suggests some limitations in the neuroprotective potential of gene therapy with Bcl- 2. (C) 2000 Elsevier Science B.V. All rights reserved.